Literature DB >> 2991144

Lysis of type-I collagen by squamous carcinomas of the head and neck.

J F Burman, R L Carter.   

Abstract

Lysis of type-I collagen by squamous carcinomas of the head and neck has been studied in freshly excised tissues, xenografts and established cell lines. Investigations with 35 freshly excised tumours showed only low levels of active and total collagenase in both carcinomas and controls. A difference became apparent when the tissues were set up in explant organ culture where a significant (p less than 0.05) increase in total collagenase was found in 13/19 tumours compared with paired control tissues over a 4-week culture period. Two xenografts showed little capacity to lyse collagen in vitro and there was only limited evidence of an increase in total collagenase after explantation and growth in organ culture. Twenty tumour cell lines showed low levels of active collagenase. Total collagenase levels were significantly increased (p less than 0.05) in 4 of the cell lines derived from cancers of the tongue; this activity was sustained in subsequent passages. Six control fibroblastoid cell lines also showed low levels of active collagenase. Levels of total collagenase were consistently high, but this activity was transient and declined in subsequent passages. Co-cultivation experiments with II tumour-cell lines and 5 fibroblastoid cell lines showed some enhanced, synergistic destruction of collagen. Parallel experiments with supernatant media from the carcinoma and fibroblastoid lines showed no enhancement, indicating that intact carcinoma cells and fibroblastoid cells are required for synergistic collagenolysis to take place.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991144     DOI: 10.1002/ijc.2910360117

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.

Authors:  N Johansson; K Airola; R Grénman; A L Kariniemi; U Saarialho-Kere; V M Kähäri
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Proteolytic activity of first trimester human placenta: localization of interstitial collagenase in villous and extravillous trophoblast.

Authors:  U M Moll; B L Lane
Journal:  Histochemistry       Date:  1990

3.  Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation.

Authors:  J Hornung; A Bohnert; L Phan-Than; T Krieg; N E Fusenig
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 4.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

5.  Sequential degradation of interstitial collagen by metalloproteinases extracted from tumors of murine ascites hepatomas.

Authors:  H Koita; K Nabeshima; T Inoue; M Koono
Journal:  Clin Exp Metastasis       Date:  1991 Sep-Oct       Impact factor: 5.150

6.  Interstitial collagenase gene expression in oral squamous cell carcinoma.

Authors:  S T Gray; R J Wilkins; K Yun
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers.

Authors:  Y Otani; I Okazaki; M Arai; K Kameyama; N Wada; K Maruyama; K Yoshino; M Kitajima; Y Hosoda; M Tsuchiya
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

8.  Low incidence of ras oncogene activation in human squamous cell carcinomas.

Authors:  G Rumsby; R L Carter; B A Gusterson
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

9.  The clinical significance of MMP-1 expression in oesophageal carcinoma.

Authors:  K Yamashita; M Mori; A Kataoka; H Inoue; K Sugimachi
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.